The Effect of PAP on ISSHL Comorbided With OSA

Launched by BEIJING TSINGHUA CHANG GUNG HOSPITAL · Dec 9, 2019

Keywords

ClinConnect Summary

This clinical trial is investigating how a treatment called positive airway pressure (PAP) can help patients who have both sudden hearing loss and obstructive sleep apnea (OSA). The study is taking place at Beijing Tsinghua Changgung Hospital and is looking for participants aged 18 to 70 who have been recently diagnosed with these conditions. To qualify, individuals must have specific levels of sleep apnea severity and sudden hearing loss that started within the last week.

If you or someone you know is eligible and chooses to participate, you can expect to undergo monitoring and receive PAP treatment over the study period, which runs from December 2019 to December 2029. This research aims to understand the potential benefits of PAP for improving hearing and overall health in patients with these two conditions. It’s important to note that individuals with certain medical issues or those who have already been treated regularly with PAP will not be included in the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. aged \>= 18 and \<= 70,
• • 2. diagnosed with OSA by full-night in-lab or home-stay PSG according to AASM 2012 criteria, and AHI \> 15/h,
• • 3. diagnosed with ISSHL by AAO-HNS 2019 criteria,
• • 4. ISSHL onset within 1 week.
• Exclusion Criteria:
• • 1. sudden hearing loss with certain causes,
• • 2. with severe comorbid diseases,
• • 3. pregnant or breast-feeding women,
• • 4. AHI \<= 15/h,
• • 5. hearing threshold recovered \> 50% when included,
• • 6. previously regularly treated with PAP.